Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Gregoriadis

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Diabetes Science and Technology|June 2, 2010
Development and testing of solid dose formulations containing polysialic acid insulin conjugate: next generation of long-acting insulinRongsheng Zhang, Sanjay Jain, Martin Rowland, et al.
Biochimica Et Biophysica Acta|June 28, 2003
Polysialylated insulin: synthesis, characterization and biological activity in vivoSanjay Jain, Dale H Hreczuk-Hirst, Brenda McCormack, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 22, 2016
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation StudyAlexey Belogurov, Konstantin Zakharov, Yakov Lomakin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Diabetes Science and Technology|June 2, 2010
Development and testing of solid dose formulations containing polysialic acid insulin conjugate: next generation of long-acting insulinRongsheng Zhang, Sanjay Jain, Martin Rowland, et al.
Biochimica Et Biophysica Acta|June 28, 2003
Polysialylated insulin: synthesis, characterization and biological activity in vivoSanjay Jain, Dale H Hreczuk-Hirst, Brenda McCormack, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 22, 2016
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation StudyAlexey Belogurov, Konstantin Zakharov, Yakov Lomakin, et al.
Pageof 2